Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:08:47 EDT Fri 03 May 2024
Enter Symbol
or Name
USA
CA



News for C:MDMA from 2023-05-04 to 2024-05-03 - 45 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-05-03 11:51C:MDMAPharmala Biotech Holdings Inc0.19News ReleasePharmala launches prescriber's portal for MDMA info
2024-04-29 03:11C:MDMAPharmala Biotech Holdings Inc0.205SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-29 03:05C:MDMAPharmala Biotech Holdings Inc0.205SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-04-19 11:13C:MDMAPharmala Biotech Holdings Inc0.195News ReleasePharmala closes $750,000 private placement
2024-04-12 12:04C:MDMAPharmala Biotech Holdings Inc0.20News ReleaseRed Light Holland ships psilocybin truffles to CCrest
2024-04-10 16:47C:MDMAPharmala Biotech Holdings Inc0.195News ReleasePharmala Biotech arranges $750,000 private placement
2024-04-05 11:12C:MDMAPharmala Biotech Holdings Inc0.19News ReleasePharmala JV begins GMP production of LaNeo in Australia
2024-03-27 11:57C:MDMAPharmala Biotech Holdings Inc0.175News ReleasePharmala receives allowance for ALA-002 from USPTO
2024-03-26 13:01C:MDMAPharmala Biotech Holdings Inc0.165News ReleasePharmala Biotech to provide LaNeo MDMA to Numinus
2024-03-20 10:40C:MDMAPharmala Biotech Holdings Inc0.155News ReleasePharmala receives USPTO allowance for P-1 molecule
2024-03-20 10:36C:MDMAPharmala Biotech Holdings Inc0.155Resume TradingPharmala Biotech Holdings to resume at 8 a.m. PT
2024-03-20 09:38C:MDMAPharmala Biotech Holdings Inc0.155Halt TradingPharmala Biotech Holdings halted at 6:36 a.m. PT
2024-03-18 12:07C:MDMAPharmala Biotech Holdings Inc0.17News ReleasePharmala JV supplies first psilocybin under TGA scheme
2024-03-08 16:27C:MDMAPharmala Biotech Holdings Inc0.195News ReleasePharmala shareholders approve all resolutions at AGM
2024-03-08 09:48C:MDMAPharmala Biotech Holdings Inc0.195News ReleaseRed Light begins research to develop psilocybin APIs
2024-02-22 13:43C:MDMAPharmala Biotech Holdings Inc0.20News ReleasePharmala named as Intellectual Property Ontario client
2024-02-20 13:38C:MDMAPharmala Biotech Holdings Inc0.22News ReleasePharmala to publish drug discovery data in ACS journal
2024-02-09 10:28C:MDMAPharmala Biotech Holdings Inc0.285News ReleasePharmala to consult Red Light on psilocybin development
2024-01-31 12:52C:MDMAPharmala Biotech Holdings Inc0.235News ReleasePharmala files Q1 financials, schedules webinar
2024-01-25 12:25C:MDMAPharmala Biotech Holdings Inc0.16Resume TradingPharmala Biotech Holdings to resume at 9:45 a.m. PT
2024-01-25 12:19C:MDMAPharmala Biotech Holdings Inc0.16News ReleasePharmala receives CDSL licence from Health Canada
2024-01-25 11:52C:MDMAPharmala Biotech Holdings Inc0.16Halt TradingPharmala Biotech Holdings halted at 8:50 a.m. PT
2024-01-24 13:12C:MDMAPharmala Biotech Holdings Inc0.16News ReleasePharmala Biotech begins trading under new OTC ticker
2024-01-08 12:47C:MDMAPharmala Biotech Holdings Inc0.165News ReleasePharmala's Pharmala-1 receives USPTO approval for PPH
2023-12-29 16:14C:MDMAPharmala Biotech Holdings Inc0.125SEDAR MD & ASEDAR MD & A
2023-12-29 16:07C:MDMAPharmala Biotech Holdings Inc0.125News ReleasePharmala Biotech files fiscal 2023 financials
2023-12-29 16:07C:MDMAPharmala Biotech Holdings Inc0.125SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-11-15 12:24C:MDMAPharmala Biotech Holdings Inc0.12News ReleasePharmala, Filament release batch of GMP MDMA capsules
2023-11-09 11:45C:MDMAPharmala Biotech Holdings Inc0.11News ReleasePharmala Biotech approved for MDMA observational trial
2023-11-08 14:43C:MDMAPharmala Biotech Holdings Inc0.11News ReleasePharmala to receive banking services from Clariti
2023-11-07 11:42C:MDMAPharmala Biotech Holdings Inc0.14News ReleasePharmala Biotech ships MDMA, psilocybin to Cortexa
2023-09-25 13:07C:MDMAPharmala Biotech Holdings Inc0.16News ReleasePharmala receives 1st office action for P-1 PCT filing
2023-09-06 14:50C:MDMAPharmala Biotech Holdings Inc0.215News ReleasePharmala Biotech starts trading on OTCQB
2023-08-10 14:36C:MDMAPharmala Biotech Holdings Inc0.29News ReleasePharmala ships MDMA to Mind Medicine Australia
2023-07-31 17:16C:MDMAPharmala Biotech Holdings Inc0.30SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-31 15:23C:MDMAPharmala Biotech Holdings Inc0.30News ReleasePharmala Biotech files molecule patent
2023-07-20 11:42C:MDMAPharmala Biotech Holdings Inc0.31News ReleasePharmala Biotech receives ALA-002 guidance from MHRA
2023-07-04 10:19C:MDMAPharmala Biotech Holdings Inc0.395News ReleasePharmala to ship LaNeo MDMA order to Australia
2023-06-16 09:53C:MDMAPharmala Biotech Holdings Inc0.255News ReleasePharmala receives permit to ship MDMA to Uni. of Sydney
2023-06-12 20:14C:MDMAPharmala Biotech Holdings Inc0.33News ReleasePharmala Biotech arranges $5-million private placement
2023-06-12 09:31C:MDMAPharmala Biotech Holdings Inc0.285Resume TradingPharmala Biotech Holdings resumes at 6:30 a.m. PT
2023-06-09 16:48C:MDMAPharmala Biotech Holdings Inc0.285News ReleasePharmala receives USFDA OK for U.S. clinical trial
2023-06-09 15:07C:MDMAPharmala Biotech Holdings Inc0.30Halt TradingPharmala Biotech halted at 12:05 p.m. PT
2023-06-09 13:26C:MDMAPharmala Biotech Holdings Inc0.30News ReleasePharmala Biotech Holdings receives research grant
2023-05-16 12:17C:MDMAPharmala Biotech Holdings Inc0.435News ReleasePharmala receives Health Canada OK to supply some MDMA